225
Views
26
CrossRef citations to date
0
Altmetric
Drug Evaluation

Aripiprazole: pharmacology and evidence in bipolar disorder

, , , &
Pages 1001-1009 | Published online: 01 May 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Marija Jovanović, Katarina Vučićević & Branislava Miljković. (2020) Understanding variability in the pharmacokinetics of atypical antipsychotics – focus on clozapine, olanzapine and aripiprazole population models. Drug Metabolism Reviews 52:1, pages 1-18.
Read now
Alessandro Cuomo, Bruno Beccarini Crescenzi, Arianna Goracci, Simone Bolognesi, Nicola Giordano, Rodolfo Rossi, Edvige Facchi, Stephen M Neal & Andrea Fagiolini. (2019) Drug safety evaluation of aripiprazole in bipolar disorder. Expert Opinion on Drug Safety 18:6, pages 455-463.
Read now
Kiran Kumar Sayyaparaju, Heinz Grunze & Kostas N Fountoulakis. (2014) When to start aripiprazole therapy in patients with bipolar mania. Neuropsychiatric Disease and Treatment 10, pages 459-470.
Read now
Roger S McIntyre, Jinju Yoon, Jeanette M Jerrell & Samantha S Liauw. (2011) Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence. Neuropsychiatric Disease and Treatment 7, pages 319-323.
Read now
Guy M. Goodwin, Mocrane Abbar, Thomas E. Schlaepfer, Heinz Grunze, Rasmus W. Licht, Frank Bellivier, Konstantinos N. Fountoulakis, Alfredo Carlo Altamura, William Pitchot, Hans Ågren, Edith Holsboer-Trachsler & Eduard Vieta. (2011) Aripiprazole in patients with bipolar mania and beyond: an update of practical guidance. Current Medical Research and Opinion 27:12, pages 2285-2299.
Read now
Heinz Grunze, Eduard Vieta, Guy M. Goodwin, Charles Bowden, Rasmus W. Licht, Hans-Jürgen Möller, Siegfried Kasper, WFSBP Task Force on Treatment Guidelines for Bipolar Disorders, Heinz Grunze, Eduard Vieta, Guy M. Goodwin, Charles Bowden, Rasmus W. Licht, Hans-Jürgen Möller, Siegfried Kasper & WFSBP Task Force on Treatment Guidelines for Bipolar Disorders. (2009) The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania. The World Journal of Biological Psychiatry 10:2, pages 85-116.
Read now
Marianna Mazza, Maria Rosaria Squillacioti, Riccardo Daniele Pecora, Luigi Janiri & Pietro Bria. (2008) Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial. Expert Opinion on Pharmacotherapy 9:18, pages 3145-3149.
Read now
Roger S McIntyre, Hanna O Woldeyohannes, Batya S Yasgur, Joanna K Soczynska, Andrew Miranda & Jakub Z Konarski. (2007) Maintenance treatment in bipolar disorder: a focus on aripiprazole. Expert Review of Neurotherapeutics 7:8, pages 919-925.
Read now

Articles from other publishers (18)

Siyi Tao, Bing Chen, Xiaofang Xu, Shaohua Hu & Jing Lu. (2023) Case report: rTMS in combination with aripiprazole and sodium valproate for the maintenance treatment of rapid cycling bipolar disorder. Frontiers in Psychiatry 14.
Crossref
Joseph R. Calabrese, Raymond Sanchez, Na Jin, Joan Amatniek, Kevin Cox, Brian Johnson, Pamela P. Perry, Peter Hertel, Pedro Such, Robert D. McQuade, Margaretta Nyilas & William H. Carson. (2018) The safety and tolerability of aripiprazole once-monthly as maintenance treatment for bipolar I disorder: A double-blind, placebo-controlled, randomized withdrawal study. Journal of Affective Disorders 241, pages 425-432.
Crossref
Michael Berger, Ute Lewitzka & Florian Seemüller. (2015) Akutbehandlung manischer Episoden. DNP - Der Neurologe und Psychiater 16:12, pages 47-61.
Crossref
William R. Armstrong, Gwen M. Grimsby & Micah A. Jacobs. (2015) Pediatric Priapism Secondary to Psychotherapeutic Medications. Urology 86:2, pages 376-378.
Crossref
Suresh Mallikaarjun, John M. Kane, Patricia Bricmont, Robert McQuade, William Carson, Raymond Sanchez, Robert A. Forbes & W. Wolfgang Fleischhacker. (2013) Pharmacokinetics, tolerability and safety of aripiprazole once-monthly in adult schizophrenia: An open-label, parallel-arm, multiple-dose study. Schizophrenia Research 150:1, pages 281-288.
Crossref
Hyun-Ghang Jeong, Moon-Soo Lee, Young-Hoon Ko, Changsu Han & In-Kwa Jung. (2012) Combination Treatment With Aripiprazole and Valproic Acid for Acute Mania. Clinical Neuropharmacology 35:3, pages 97-102.
Crossref
Konstantinos N. Fountoulakis, Eduard Vieta & Frank Schmidt. (2011) Aripiprazole monotherapy in the treatment of bipolar disorder: A meta-analysis. Journal of Affective Disorders 133:3, pages 361-370.
Crossref
Kinga Burda, Anna Czubak, Krzysztof Kus, Elżbieta Nowakowska, Piotr Ratajczak & Jennifer Zin. (2011) Influence of aripiprazole on the antidepressant, anxiolytic and cognitive functions of rats. Pharmacological Reports 63:4, pages 898-907.
Crossref
Alexander C. Tsai, Nicholas Z. Rosenlicht, Jon N. Jureidini, Peter I. Parry, Glen I. Spielmans & David Healy. (2011) Aripiprazole in the Maintenance Treatment of Bipolar Disorder: A Critical Review of the Evidence and Its Dissemination into the Scientific Literature. PLoS Medicine 8:5, pages e1000434.
Crossref
Maria Sierra Peña, Toby C. Yaltho & Joseph Jankovic. (2010) Tardive dyskinesia and other movement disorders secondary to aripiprazole. Movement Disorders 26:1, pages 147-152.
Crossref
Pasquale De Fazio, Paolo Girardi, Giuseppe Maina, Massimo Carlo Mauri, Mauro Mauri, Palmiero Monteleone, Giulia Ida Perini, Giulio Perugi & Alessandro Rossi. (2010) Aripiprazole in Acute Mania and Long-Term Treatment of Bipolar Disorder. Clinical Drug Investigation 30:12, pages 827-841.
Crossref
John M KaneThomas RE Barnes, Christoph U Correll, Gary Sachs, Peter Buckley, James Eudicone, Robert McQuade, Quynh-Van Tran, Andrei PikalovIIIIII & Sheila Assunção-Talbott. (2009) Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials. Journal of Psychopharmacology 24:7, pages 1019-1029.
Crossref
Roger S. McIntyre. (2010) Foreword. Clinical Therapeutics 32, pages S1-S2.
Crossref
Konstantinos N Fountoulakis, Xenia Gonda, Eduard Vieta & Frank Schmidt. (2009) Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis. Annals of General Psychiatry 8:1.
Crossref
Konstantinos N Fountoulakis & Eduard Vieta. (2009) Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review. Annals of General Psychiatry 8:1.
Crossref
Marianna Mazza, Maria Rosaria Squillacioti, Riccardo Daniele Pecora, Luigi Janiri & Pietro Bria. (2009) Effect of aripiprazole on self-reported anhedonia in bipolar depressed patients. Psychiatry Research 165:1-2, pages 193-196.
Crossref
Robert L. Findling, Ralph E. Kauffman, Floyd R. Sallee, William H. Carson, Margaretta Nyilas, Suresh Mallikaarjun, Susan E. Shoaf, Robert A. Forbes, David W. Boulton & Andrei Pikalov. (2008) Tolerability and Pharmacokinetics of Aripiprazole in Children and Adolescents With Psychiatric Disorders. Journal of Clinical Psychopharmacology 28:4, pages 441-446.
Crossref
Srijan Sen & Gerard Sanacora. (2008) Major depression: emerging therapeutics. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 75:3, pages 204-225.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.